Last reviewed · How we verify

NCT07124260: CGTCMPDOR

Characterization of Gut and Tongue Coating Microbiota in Patients With Diminished Ovarian Reserve

Recruiting now Last updated 26 August 2025
What this trial tests

trial testing gut microbiota in Diminished Ovarian Reserve in 200 participants. Currently enrolling.

Timeline
28 January 2025
Primary endpoint
1 December 2025
31 December 2025

Quick facts

Lead sponsorHangzhou TCM Hospital Affiliated to Zhejiang Chinese Medical University
StatusRecruiting now
Study typeOBSERVATIONAL
Enrollment200
Start date28 January 2025
Primary completion1 December 2025
Estimated completion31 December 2025
Sites1 location across China

Drugs / interventions tested

Conditions studied

Sponsor

Hangzhou TCM Hospital Affiliated to Zhejiang Chinese Medical University

Who can join

20 and older, female only, with Diminished Ovarian Reserve. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The goal of this observational study is to investigate the distinct tongue manifestation characteristics in patients with diminished ovarian reserve (DOR) compared to healthy individuals, and to clarify the features of tongue coating microbiota, gut microbiota, and their interrelationships in DOR patients. The main question it aims to answer is: Whether there are significant differences in tongue manifestations, tongue coating microbiota, and gut microbiota characteristics between DOR patients and healthy populations; Whether associations exist between tongue coating microbiota and gut microbiota in DOR patients; Whether the pathogenesis of DOR may influence estrogen metabolism through alterations in oral and gut microbiota.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of gut microbiota

Trials testing the same drug.

Other recruiting trials for Diminished Ovarian Reserve

Currently open trials in the same condition.

Other Hangzhou TCM Hospital Affiliated to Zhejiang Chinese Medical University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07124260.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing